Oscar Juan

Oscar Juan

UNVERIFIED PROFILE

Are you Oscar Juan?   Register this Author

Register author
Oscar Juan

Oscar Juan

Publications by authors named "Oscar Juan"

Are you Oscar Juan?   Register this Author

29Publications

615Reads

46Profile Views

Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases.

Crit Rev Oncol Hematol 2019 Jun 3;138:190-206. Epub 2019 Apr 3.

Clinical Research in Solid Tumors (CReST) and Neuro-Oncology Group. Oncobell, IDIBELL, Avda Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain; Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology. Avda Gran Via 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2019.03.017DOI Listing
June 2019

LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics.

Anal Chem 2019 Jan 13;91(1):836-845. Epub 2018 Dec 13.

Biomarkers and Precision Medicine Unit and Analytical Unit , Instituto de Investigación Sanitaria Fundación Hospital La Fe , Valencia 46026 , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.8b03409DOI Listing
January 2019

Lung brain metastasis pseudoprogression after nivolumab and ipilimumab combination treatment.

Thorac Cancer 2018 12 1;9(12):1770-1773. Epub 2018 Oct 1.

Department of Medical Oncology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/1759-7714.12873
Publisher Site
http://dx.doi.org/10.1111/1759-7714.12873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275812PMC
December 2018

Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

Clin Lung Cancer 2017 11 14;18(6):595-606. Epub 2017 Mar 14.

Lung Unit, Royal Marsden Hospital, London, United Kingdom; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom; and the Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.03.002DOI Listing
November 2017

Translating cancer epigenomics into the clinic: focus on lung cancer.

Transl Res 2017 11 2;189:76-92. Epub 2017 Jun 2.

Biomarkers and Precision Medicine Unit. Health Research Institute La Fe, Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2017.05.008DOI Listing
November 2017

Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients.

Lung Cancer 2017 02 11;104:131-133. Epub 2016 Nov 11.

Lung Unit, Royal Marsden Hospital, London SW3 6JJ, UK; National Heart & Lung Institute, Faculty of Medicine, Imperial College London, Guy Scadding Building, Cale Street, London SW3 6LY, UK; The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002163052
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2016.11.007DOI Listing
February 2017

Atrial flutter and myocardial infarction-like ECG changes as manifestations of left ventricle involvement from lung carcinoma.

Clin Transl Oncol 2008 Feb;10(2):125-7

Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12094-008-0166
Web Search
February 2008

Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.

Acta Oncol 2007 ;46(3):367-73

Department of Medical Oncology, Hospital Arnau de Vilanova, San Clemente 12, Valencia 46015, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02841860600833178DOI Listing
October 2007

Influence of the cyto-protective agent amifostine on the pharmacokinetics of low-dose Paclitaxel.

Chemotherapy 2005 Jul 28;51(4):200-5. Epub 2005 Jun 28.

Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000086597DOI Listing
July 2005

Megestrol acetate-probably less effective than has been reported!

J Pain Symptom Manage 2005 Jul;30(1):4; author reply 5-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2005.05.003DOI Listing
July 2005

Ifosfamide-induced psychosis.

Acta Oncol 2004 ;43(1):119-20

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02841860310015902DOI Listing
April 2004

Weekly paclitaxel in the treatment of metastatic and/or recurrent non-small cell lung cancer.

Crit Rev Oncol Hematol 2002 Dec;44 Suppl:S31-41

Oncology Department, Hospital Arnau de Vilanova, C/San Clemente 12, 46010 Valencia, Spain.

View Article

Download full-text PDF

Source
December 2002

Low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer: a phase II study.

Jpn J Clin Oncol 2002 Nov;32(11):449-54

Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyf098DOI Listing
November 2002